+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Nephrostomy Devices Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

  • PDF Icon


  • 100 Pages
  • January 2022
  • Region: Global
  • Mordor Intelligence
  • ID: 4987066

The Nephrostomy Devices Market is expected to register a CAGR of 7.8% during the forecast period. Nephrostomy devices are used for creating an artificial opening between the kidney and the skin which allows for the urinary diversion directly from the upper part of the urinary system (renal pelvis). Nephrostomy is commonly performed in the case of cancer of reproductive organs such as ovarian cancer, colon cancer, etc. Nephrostomy is also recommended in some other indications such as urinary tract infections, urinary incontinence, benign prostate hyperplasia, bladder prolapse, etc.

According to a study published in Advances in Urology, Kidney stone disease is an increasing urological disorder of human health which is affecting about 15% of the world population and it affects all age groups but occurs more frequently in men than in women within the age of 20-49 years.

Increasing cases of kidney stone disorder, increasing prevalence of ovarian, bladder, and prostate cancers, rise in demand for minimally invasive surgical procedures, and increased awareness about the product are the key driving factors in nephrostomy devices market.

Key Market Trends

Guidewires Segment is Expected to Hold a Major Market Share in the Nephrostomy Devices Market

  • A guidewire is a useful tool for obtaining access to and facilitating passage through various luminal structures. Urological Guidewires are intended to facilitate the placement of endourological instruments during diagnostic or interventional procedures.
  • According to the American Academy of Family Physicians (AAFP), Kidney stones are a common disorder, with an annual incidence of eight cases per 1,000 adults. In addition, around 13% of men and 7% of women develop kidney stone in their lifetime. furthermore, the overall incidence of urinary retention is 4.5 to 6.8 per 1,000 men, per year, in the United States.
  • Guidewires segment holds a significant market share in the nephrostomy devices market and is anticipated to show a similar trend over the forecast period due to the less-invasive nature of the product.
  • Increasing cases of kidney stone disorder, increasing prevalence of ovarian, bladder, and prostate cancers, rise in demand for minimally invasive surgical procedures are the key driving factors in the guidewires segment.

North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period

North America is expected to hold a major market share in the global nephrostomy devices market due to increasing cases of kidney stone disorder, a rise in demand for minimally invasive surgical procedures and the availability of skilled surgeons in this region. According to a study published in the Clinical Journal of the American Society of Nephrology, in the United States, 1 in 11 individuals will experience a urinary stone in their lifetime. In addition, the frequency of urinary stone disease (USD) in children is increasing (4%-6%) yearly, particularly among adolescents. Furthermore, an increase in percutaneous nephrostomy procedures, quick adoption of advanced medical tools and presence of well-established healthcare infrastructure is also fueling the growth of the overall regional market to a large extent.

Competitive Landscape

The Nephrostomy Devices Market is fragmented competitive and consists of several major players. In terms of market share, few of the major players are currently dominating the market. Some of the companies which are currently dominating the market are Boston Scientific Corporation, Teleflex Incorporated, Cardinal Health, Becton, Dickinson and Company, B. Braun Melsungen AG, Cook Medical Incorporated, Coloplast Group, Argon Medical, Angiodynamics Inc and Envaste Limited.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

This product will be delivered within 2 business days.

Table of Contents

1.1 Study Assumptions
1.2 Scope of the Study
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Cases of kidney Stone Disorders
4.2.2 Rise in Demand for Minimally Invasive Surgeries
4.2.3 Technological Advancements in Nephrostomy Devices
4.3 Market Restraints
4.3.1 Alternative Procedures Such as Ureteral Stenting
4.3.2 Risk Associated with Nephrostomy Procedure
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5.1 By Product Type
5.1.1 Drainage Tubes
5.1.2 Dilators Sheaths
5.1.3 Guidewires
5.1.4 Nephrostomy Catheters
5.1.5 Other Products
5.2 Geography
5.2.1 North America United States Canada Mexico
5.2.2 Europe Germany United Kingdom France Italy Spain Rest of Europe
5.2.3 Asia-Pacific China Japan India Australia South Korea Rest of Asia-Pacific
5.2.4 Middle-East and Africa GCC South Africa Rest of Middle-East and Africa
5.2.5 South America Brazil Argentina Rest of South America
6.1 Company Profiles
6.1.1 Boston Scientific Corporation
6.1.2 Teleflex Incorporated
6.1.3 Cardinal Health
6.1.4 Becton, Dickinson and Company
6.1.5 B. Braun Melsungen AG
6.1.6 Cook Medical Incorporated
6.1.7 Coloplast Group
6.1.8 Argon Medical
6.1.9 Angiodynamics Inc
6.1.10 Envaste Limited

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Boston Scientific Corporation
  • Teleflex Incorporated
  • Cardinal Health
  • Becton, Dickinson and Company
  • B. Braun Melsungen AG
  • Cook Medical Incorporated
  • Coloplast Group
  • Argon Medical
  • Angiodynamics Inc
  • Envaste Limited